Europe Equine Healthcare Market Size, Share & Trends Analysis Report By Product Type, By Indication (Musculoskeletal Disorders, Parasitic Infections, Equine Influenza), By Activity Type, By Distribution Channel, By Country, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Europe Equine Healthcare Market Growth & Trends
The Europe equine healthcare market size is estimated to reach USD 1.88 billion by 2030 and is projected to register a CAGR of 6.87% from 2024 to 2030, according to a new report by Grand View Research, Inc. The region is experiencing a dynamic growth in the field of equestrian activities. As per February 2024 data by Global Pet Industry, Europe has over 6 million equine population, and the use of these horses for sporting purposes is gaining popularity. As per 2024 estimates by the European Equestrian Business Association (EEBA), equestrian activities in the region generate over USD 111 billion in revenue and employ over 400,000 people. Equestrianism is believed to contribute to society in general in terms of maintaining physical & mental health.
Equestrian activities are an inherent part of the cultural traditions in the region. Moreover, the pandemic further boosted the various types of equine products (health and other products) due to horse owners being restricted to their homes during the global lockdown. This led to increased use of equine companions by owners to distract themselves from the global crisis. Naturally, awareness of these owners about the health of their horses increased. These equine health products were over-ordered but understocked due to a huge surge in demand.
Furthermore, according to the European Federation of Thoroughbred Breeders Association (EFTBA), Europe is estimated to be home to approximately 22% of the world's gallop/racing horses. In addition, thoroughbred horses from Europe are recognized as the best horses for racing/sports activities worldwide. According to EFTBA, over 23,000 thoroughbred breeders from the region have been acclaimed internationally for the quality of their horses. It is estimated that over 100,000 hectares of land have been separately assigned for the breeding activities of horses. These activities naturally lead to the need to diagnose and treat these horses to maintain a healthy race/sports horse.
The equine-assisted therapy has been gaining popularity in recent years. Professionals guide individuals to overcome their own physical or mental health conditions by using specially trained horses. This therapy usually works in tandem with cognitive behavioral therapy and experiential therapy. Equine-assisted therapies offer many benefits for individuals suffering from conditions like behavioral problems, grief, anxiety, depression, Attention-deficit/Hyperactivity Disorder (ADHD), and addictions. These therapies also offer specialized riding programs that help patients enhance their balance, strength, endurance, agility, and spatial awareness.
The adoption of orthobiologics in equine health has been on the rise globally. Orthobiologics help repair, replace, regenerate, and restore tissues, cells, etc., in horses. Platelet-rich Plasma (PRP) and stem cell therapies are the most widely used orthobiologics in the equine population, but many are currently under development. The development of innovative products like extracellular-vesicle-based products, bone marrow aspirate concentrate, autologous bone marrow monocellular fraction, and liquid amnion allograft are being explored by researchers to treat various conditions in horses. Such research developments promote the discovery of innovative ways to treat health conditions among the equine population effectively.
Various digital technology advancements have impacted the equine healthcare market. Veterinary software companies from the region are collaborating with institutions to advance the digital footprint of equine health-related data. For instance, in April 2023, The Ballindenisk International, an equestrian facility based in Ireland, collaborated with an Ireland-based company, Equine MediRecord, to help enhance the bio-security of horses and athletes participating in various equestrian events. All the vaccines, as well as other health-related records of the horses, were checked and secured in advance to avoid disease outbreaks during the previous year’s event.
Furthermore, manufacturers, as well as educational & research institutions, are also contributing toward advancing the equine health industry in the region by developing novel technologies that are unique for horses. For example, the Royal Veterinary College (RVC), in July 2023, launched the UK’s first Computed Tomography scanner (CT scanner), designed specifically for application in horses to improve the accuracy of diagnostic examinations and treatment.
In addition, Hungary-based Control-X Medical Zrt, in October 2022, launched the world’s first Radiography & Fluoroscopy Diagnostic Imaging System (R&F System) for horses. This product has applications in gastrointestinal examinations and diagnosis of unique joint conditions.
Europe Equine Healthcare Market Report Highlights
Europe Equine Healthcare Market Growth & Trends
The Europe equine healthcare market size is estimated to reach USD 1.88 billion by 2030 and is projected to register a CAGR of 6.87% from 2024 to 2030, according to a new report by Grand View Research, Inc. The region is experiencing a dynamic growth in the field of equestrian activities. As per February 2024 data by Global Pet Industry, Europe has over 6 million equine population, and the use of these horses for sporting purposes is gaining popularity. As per 2024 estimates by the European Equestrian Business Association (EEBA), equestrian activities in the region generate over USD 111 billion in revenue and employ over 400,000 people. Equestrianism is believed to contribute to society in general in terms of maintaining physical & mental health.
Equestrian activities are an inherent part of the cultural traditions in the region. Moreover, the pandemic further boosted the various types of equine products (health and other products) due to horse owners being restricted to their homes during the global lockdown. This led to increased use of equine companions by owners to distract themselves from the global crisis. Naturally, awareness of these owners about the health of their horses increased. These equine health products were over-ordered but understocked due to a huge surge in demand.
Furthermore, according to the European Federation of Thoroughbred Breeders Association (EFTBA), Europe is estimated to be home to approximately 22% of the world's gallop/racing horses. In addition, thoroughbred horses from Europe are recognized as the best horses for racing/sports activities worldwide. According to EFTBA, over 23,000 thoroughbred breeders from the region have been acclaimed internationally for the quality of their horses. It is estimated that over 100,000 hectares of land have been separately assigned for the breeding activities of horses. These activities naturally lead to the need to diagnose and treat these horses to maintain a healthy race/sports horse.
The equine-assisted therapy has been gaining popularity in recent years. Professionals guide individuals to overcome their own physical or mental health conditions by using specially trained horses. This therapy usually works in tandem with cognitive behavioral therapy and experiential therapy. Equine-assisted therapies offer many benefits for individuals suffering from conditions like behavioral problems, grief, anxiety, depression, Attention-deficit/Hyperactivity Disorder (ADHD), and addictions. These therapies also offer specialized riding programs that help patients enhance their balance, strength, endurance, agility, and spatial awareness.
The adoption of orthobiologics in equine health has been on the rise globally. Orthobiologics help repair, replace, regenerate, and restore tissues, cells, etc., in horses. Platelet-rich Plasma (PRP) and stem cell therapies are the most widely used orthobiologics in the equine population, but many are currently under development. The development of innovative products like extracellular-vesicle-based products, bone marrow aspirate concentrate, autologous bone marrow monocellular fraction, and liquid amnion allograft are being explored by researchers to treat various conditions in horses. Such research developments promote the discovery of innovative ways to treat health conditions among the equine population effectively.
Various digital technology advancements have impacted the equine healthcare market. Veterinary software companies from the region are collaborating with institutions to advance the digital footprint of equine health-related data. For instance, in April 2023, The Ballindenisk International, an equestrian facility based in Ireland, collaborated with an Ireland-based company, Equine MediRecord, to help enhance the bio-security of horses and athletes participating in various equestrian events. All the vaccines, as well as other health-related records of the horses, were checked and secured in advance to avoid disease outbreaks during the previous year’s event.
Furthermore, manufacturers, as well as educational & research institutions, are also contributing toward advancing the equine health industry in the region by developing novel technologies that are unique for horses. For example, the Royal Veterinary College (RVC), in July 2023, launched the UK’s first Computed Tomography scanner (CT scanner), designed specifically for application in horses to improve the accuracy of diagnostic examinations and treatment.
In addition, Hungary-based Control-X Medical Zrt, in October 2022, launched the world’s first Radiography & Fluoroscopy Diagnostic Imaging System (R&F System) for horses. This product has applications in gastrointestinal examinations and diagnosis of unique joint conditions.
Europe Equine Healthcare Market Report Highlights
- By product type, the pharmaceuticals segment dominated the market with a share of over 25.61% in 2023 and is expected to grow at a CAGR of 6.34% during the forecast period due to the rising prevalence of equine health conditions and different types of pharmaceuticals being the primary form of treatment prescribed by veterinarians to treat these conditions
- In terms of indication, the parasitic infections segment held the largest market share in 2023, and the equine influenza segment is projected to register the fastest growth rate from 2024 to 2030 owing to the high prevalence of these conditions among European horses
- In terms of activity type, the sports/racing segment accounted for the largest market share in 2023. Equestrian activities like racing and sports are some of the most popular types of sports across Europe. An increase in these activities leads to a rise in the need for appropriate diagnosis, treatment, and prevention of diseases among these sports horses. This ultimately leads to growth in consumption of equine health products, providing lucrative growth prospects
- By distribution channel, veterinary hospitals/clinics segment held the largest market share in 2023 due to rising demand for specialized as well as well-equipped healthcare services for horses participating in activities like equine-assisted therapy, horse riding, and equine sports
- By country, the UK held the largest share of about 23.94% in 2023. In addition, Germany held the second-largest share in the market
- High prevalence of equine diseases in Europe, growth of equestrian activities, use of advanced technologies in equine health management, and increasing horse population across Europe are expected to drive market growth
CHAPTER 1. RESEARCH METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.1.2. Product type
1.1.3. Indication
1.1.4. Activity type
1.2. Regional Scope
1.3. Estimates And Forecast Timeline
1.4. Objectives
1.4.1. Objective -
1.4.2. Objective -
1.4.3. Objective -
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.9.2. Parent Market Analysis
1.10. List Of Secondary Sources
1.11. List Of Abbreviations
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. EUROPE EQUINE HEALTHCARE MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. High Prevalence Of Equine Diseases In Europe
3.2.1.2. Growth Of Equestrian Activities
3.2.1.3. Use of Advanced Technologies In Equine Health Management
3.2.1.4. Increasing Horse Population Across Europe
3.2.2. Market Restraint Analysis
3.2.2.1. High Cost of Expenditure
3.2.2.2. Availability of Substitutes
3.3. Europe Equine Healthcare Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat Of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTEL Analysis
3.3.3. Porters Analysis
3.3.4. COVID-19 Impact Analysis
CHAPTER 4. EUROPE EQUINE HEALTHCARE MARKET: PRODUCT TYPE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Europe Equine Healthcare Market Movement Analysis
4.3. Europe Equine Healthcare Market Size & Trend Analysis, By Product Type, 2018 - 2030 (USD Million)
4.3.1. Vaccines
4.3.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2. Pharmaceuticals
4.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2.2. Parasiticides
4.3.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2.3. Anti-infectives
4.3.2.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2.4. Anti-inflammatory & Analgesics
4.3.2.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2.5. Other Pharmaceuticals
4.3.2.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.3. Medicinal Feed Additives
4.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.4. Orthobiologics
4.3.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.5. Diagnostics
4.3.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.5.2. Diagnostic Test Kits
4.3.5.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.5.3. Diagnostic Equipment
4.3.5.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.6. Software
4.3.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.6.2. Practice Management Software
4.3.6.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.6.3. Imaging Software
4.3.6.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.6.4. Telehealth Software
4.3.6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.6.5. Other Software
4.3.6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.7. Other Products
4.3.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 5. EUROPE EQUINE HEALTHCARE MARKET: INDICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Europe Equine Healthcare Market Movement Analysis
5.3. Europe Equine Healthcare Market Size & Trend Analysis, Indication, 2018 - 2030 (USD Million)
5.3.1. Musculoskeletal Disorders
5.3.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.2. Parasitic Infections
5.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.3. Equine Herpes Virus
5.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.4. Equine Viral Arteritis (EVA)
5.3.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.5. Equine Influenza
5.3.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.6. West Nile Virus
5.3.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.7. Tetanus
5.3.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.8. Other Indications
5.3.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 6. EUROPE EQUINE HEALTHCARE MARKET: ACTIVITY TYPE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Europe Equine Healthcare Market Movement Analysis
6.3. Europe Equine Healthcare Market Size & Trend Analysis, Activity Type, 2018 - 2030 (USD Million)
6.3.1. Sports/Racing
6.3.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.2. Recreation
6.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.3. Other Activities
6.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 7. EUROPE EQUINE HEALTHCARE MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Europe Equine Healthcare Market Movement Analysis
7.3. Europe Equine Healthcare Market Size & Trend Analysis, By Distribution Channel, 2018 - 2030 (USD Million)
7.3.1. Veterinary Hospitals & Clinics
7.3.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.3.2. E-commerce
7.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.3.3. Equestrian Facilities
7.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.3.4. Other Channels
7.3.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 8. EUROPE EQUINE HEALTHCARE MARKET: COUNTRY ESTIMATES & TREND ANALYSIS, BY PRODUCT TYPE, INDICATION, ACTIVITY TYPE & DISTRIBUTION CHANNEL
8.1. Country Dashboard
8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
8.3. Germany
8.3.1. Key Country Dynamics
8.3.2. Competitive Scenario
8.3.3. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. UK
8.4.1. Key Country Dynamics
8.4.2. Competitive Scenario
8.4.3. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. France
8.5.1. Key Country Dynamics
8.5.2. Competitive Scenario
8.5.3. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Italy
8.6.1. Key Country Dynamics
8.6.2. Competitive Scenario
8.6.3. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7. Spain
8.7.1. Key Country Dynamics
8.7.2. Competitive Scenario
8.7.3. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8. Sweden
8.8.1. Key Country Dynamics
8.8.2. Competitive Scenario
8.8.3. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.9. Norway
8.9.1. Key Country Dynamics
8.9.2. Competitive Scenario
8.9.3. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.10. Denmark
8.10.1. Key Country Dynamics
8.10.2. Competitive Scenario
8.10.3. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.11. Netherlands
8.11.1. Key Country Dynamics
8.11.2. Competitive Scenario
8.11.3. Netherlands Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.12. Russia
8.12.1. Key Country Dynamics
8.12.2. Competitive Scenario
8.12.3. Russia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.13. Switzerland
8.13.1. Key Country Dynamics
8.13.2. Competitive Scenario
8.13.3. Switzerland Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Market Participant Categorization
9.2. Participants Overview
9.3. Financial Performance
9.4. Product Benchmarking
9.5. Market Position Analysis, 2023 (Heat Map Analysis)
9.6. Strategy Mapping
9.6.1. Mergers And Acquisitions
9.6.2. Launch
9.6.3. Partnerships & Collaborations
9.6.4. Expansion
9.6.5. Others
9.7. Company Profiles
9.7.1. Zoetis
9.7.1.1. Participant’s overview
9.7.1.2. Financial performance
9.7.1.3. Product benchmarking
9.7.1.4. Strategic initiatives
9.7.2. Arthrex Inc.
9.7.2.1. Participant’s overview
9.7.2.2. Financial performance
9.7.2.3. Product benchmarking
9.7.2.4. Strategic initiatives
9.7.3. Dechra Pharmaceuticals
9.7.3.1. Participant’s overview
9.7.3.2. Financial performance
9.7.3.3. Product benchmarking
9.7.3.4. Strategic initiatives
9.7.4. Boehringer Ingelheim
9.7.4.1. Participant’s overview
9.7.4.2. Financial performance
9.7.4.3. Product benchmarking
9.7.4.4. Strategic initiatives
9.7.5. Ceva Sante Animale
9.7.5.1. Participant’s overview
9.7.5.2. Financial performance
9.7.5.3. Product benchmarking
9.7.5.4. Strategic initiatives
9.7.6. Heska Corporation
9.7.6.1. Participant’s overview
9.7.6.2. Financial performance
9.7.6.3. Product benchmarking
9.7.6.4. Strategic initiatives
9.7.7. Merck & Co Inc.
9.7.7.1. Participant’s overview
9.7.7.2. Financial performance
9.7.7.3. Product benchmarking
9.7.7.4. Strategic initiatives
9.7.8. Esaote SpA
9.7.8.1. Participant’s overview
9.7.8.2. Financial performance
9.7.8.3. Product benchmarking
9.7.8.4. Strategic initiatives
9.7.9. IDEXX Laboratories Inc.
9.7.9.1. Participant’s overview
9.7.9.2. Financial performance
9.7.9.3. Product benchmarking
9.7.9.4. Strategic initiatives
9.7.10. Covetrus Inc.
9.7.10.1. Participant’s overview
9.7.10.2. Financial performance
9.7.10.3. Product benchmarking
9.7.10.4. Strategic initiatives
9.7.11. Elanco
9.7.11.1. Participant’s overview
9.7.11.2. Financial performance
9.7.11.3. Product benchmarking
9.7.11.4. Strategic initiatives
9.7.12. Cargill
9.7.12.1. Participant’s overview
9.7.12.2. Financial performance
9.7.12.3. Product benchmarking
9.7.12.4. Strategic initiatives
9.8. List of Other Key Market Players
CHAPTER 10. KEY TAKEAWAYS
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.1.2. Product type
1.1.3. Indication
1.1.4. Activity type
1.2. Regional Scope
1.3. Estimates And Forecast Timeline
1.4. Objectives
1.4.1. Objective -
1.4.2. Objective -
1.4.3. Objective -
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.9.2. Parent Market Analysis
1.10. List Of Secondary Sources
1.11. List Of Abbreviations
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. EUROPE EQUINE HEALTHCARE MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. High Prevalence Of Equine Diseases In Europe
3.2.1.2. Growth Of Equestrian Activities
3.2.1.3. Use of Advanced Technologies In Equine Health Management
3.2.1.4. Increasing Horse Population Across Europe
3.2.2. Market Restraint Analysis
3.2.2.1. High Cost of Expenditure
3.2.2.2. Availability of Substitutes
3.3. Europe Equine Healthcare Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat Of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTEL Analysis
3.3.3. Porters Analysis
3.3.4. COVID-19 Impact Analysis
CHAPTER 4. EUROPE EQUINE HEALTHCARE MARKET: PRODUCT TYPE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Europe Equine Healthcare Market Movement Analysis
4.3. Europe Equine Healthcare Market Size & Trend Analysis, By Product Type, 2018 - 2030 (USD Million)
4.3.1. Vaccines
4.3.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2. Pharmaceuticals
4.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2.2. Parasiticides
4.3.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2.3. Anti-infectives
4.3.2.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2.4. Anti-inflammatory & Analgesics
4.3.2.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2.5. Other Pharmaceuticals
4.3.2.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.3. Medicinal Feed Additives
4.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.4. Orthobiologics
4.3.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.5. Diagnostics
4.3.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.5.2. Diagnostic Test Kits
4.3.5.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.5.3. Diagnostic Equipment
4.3.5.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.6. Software
4.3.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.6.2. Practice Management Software
4.3.6.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.6.3. Imaging Software
4.3.6.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.6.4. Telehealth Software
4.3.6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.6.5. Other Software
4.3.6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.7. Other Products
4.3.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 5. EUROPE EQUINE HEALTHCARE MARKET: INDICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Europe Equine Healthcare Market Movement Analysis
5.3. Europe Equine Healthcare Market Size & Trend Analysis, Indication, 2018 - 2030 (USD Million)
5.3.1. Musculoskeletal Disorders
5.3.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.2. Parasitic Infections
5.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.3. Equine Herpes Virus
5.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.4. Equine Viral Arteritis (EVA)
5.3.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.5. Equine Influenza
5.3.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.6. West Nile Virus
5.3.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.7. Tetanus
5.3.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.8. Other Indications
5.3.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 6. EUROPE EQUINE HEALTHCARE MARKET: ACTIVITY TYPE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Europe Equine Healthcare Market Movement Analysis
6.3. Europe Equine Healthcare Market Size & Trend Analysis, Activity Type, 2018 - 2030 (USD Million)
6.3.1. Sports/Racing
6.3.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.2. Recreation
6.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.3. Other Activities
6.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 7. EUROPE EQUINE HEALTHCARE MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Europe Equine Healthcare Market Movement Analysis
7.3. Europe Equine Healthcare Market Size & Trend Analysis, By Distribution Channel, 2018 - 2030 (USD Million)
7.3.1. Veterinary Hospitals & Clinics
7.3.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.3.2. E-commerce
7.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.3.3. Equestrian Facilities
7.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
7.3.4. Other Channels
7.3.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 8. EUROPE EQUINE HEALTHCARE MARKET: COUNTRY ESTIMATES & TREND ANALYSIS, BY PRODUCT TYPE, INDICATION, ACTIVITY TYPE & DISTRIBUTION CHANNEL
8.1. Country Dashboard
8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
8.3. Germany
8.3.1. Key Country Dynamics
8.3.2. Competitive Scenario
8.3.3. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. UK
8.4.1. Key Country Dynamics
8.4.2. Competitive Scenario
8.4.3. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. France
8.5.1. Key Country Dynamics
8.5.2. Competitive Scenario
8.5.3. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Italy
8.6.1. Key Country Dynamics
8.6.2. Competitive Scenario
8.6.3. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7. Spain
8.7.1. Key Country Dynamics
8.7.2. Competitive Scenario
8.7.3. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8. Sweden
8.8.1. Key Country Dynamics
8.8.2. Competitive Scenario
8.8.3. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.9. Norway
8.9.1. Key Country Dynamics
8.9.2. Competitive Scenario
8.9.3. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.10. Denmark
8.10.1. Key Country Dynamics
8.10.2. Competitive Scenario
8.10.3. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.11. Netherlands
8.11.1. Key Country Dynamics
8.11.2. Competitive Scenario
8.11.3. Netherlands Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.12. Russia
8.12.1. Key Country Dynamics
8.12.2. Competitive Scenario
8.12.3. Russia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.13. Switzerland
8.13.1. Key Country Dynamics
8.13.2. Competitive Scenario
8.13.3. Switzerland Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Market Participant Categorization
9.2. Participants Overview
9.3. Financial Performance
9.4. Product Benchmarking
9.5. Market Position Analysis, 2023 (Heat Map Analysis)
9.6. Strategy Mapping
9.6.1. Mergers And Acquisitions
9.6.2. Launch
9.6.3. Partnerships & Collaborations
9.6.4. Expansion
9.6.5. Others
9.7. Company Profiles
9.7.1. Zoetis
9.7.1.1. Participant’s overview
9.7.1.2. Financial performance
9.7.1.3. Product benchmarking
9.7.1.4. Strategic initiatives
9.7.2. Arthrex Inc.
9.7.2.1. Participant’s overview
9.7.2.2. Financial performance
9.7.2.3. Product benchmarking
9.7.2.4. Strategic initiatives
9.7.3. Dechra Pharmaceuticals
9.7.3.1. Participant’s overview
9.7.3.2. Financial performance
9.7.3.3. Product benchmarking
9.7.3.4. Strategic initiatives
9.7.4. Boehringer Ingelheim
9.7.4.1. Participant’s overview
9.7.4.2. Financial performance
9.7.4.3. Product benchmarking
9.7.4.4. Strategic initiatives
9.7.5. Ceva Sante Animale
9.7.5.1. Participant’s overview
9.7.5.2. Financial performance
9.7.5.3. Product benchmarking
9.7.5.4. Strategic initiatives
9.7.6. Heska Corporation
9.7.6.1. Participant’s overview
9.7.6.2. Financial performance
9.7.6.3. Product benchmarking
9.7.6.4. Strategic initiatives
9.7.7. Merck & Co Inc.
9.7.7.1. Participant’s overview
9.7.7.2. Financial performance
9.7.7.3. Product benchmarking
9.7.7.4. Strategic initiatives
9.7.8. Esaote SpA
9.7.8.1. Participant’s overview
9.7.8.2. Financial performance
9.7.8.3. Product benchmarking
9.7.8.4. Strategic initiatives
9.7.9. IDEXX Laboratories Inc.
9.7.9.1. Participant’s overview
9.7.9.2. Financial performance
9.7.9.3. Product benchmarking
9.7.9.4. Strategic initiatives
9.7.10. Covetrus Inc.
9.7.10.1. Participant’s overview
9.7.10.2. Financial performance
9.7.10.3. Product benchmarking
9.7.10.4. Strategic initiatives
9.7.11. Elanco
9.7.11.1. Participant’s overview
9.7.11.2. Financial performance
9.7.11.3. Product benchmarking
9.7.11.4. Strategic initiatives
9.7.12. Cargill
9.7.12.1. Participant’s overview
9.7.12.2. Financial performance
9.7.12.3. Product benchmarking
9.7.12.4. Strategic initiatives
9.8. List of Other Key Market Players
CHAPTER 10. KEY TAKEAWAYS
LIST OF TABLES
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Europe Equine Healthcare Market, Product Type, 2018 - 2030 (USD Million)
Table 4 Europe Equine Healthcare Market, Indication, 2018 - 2030 (USD Million)
Table 5 Europe Equine Healthcare Market, Activity Type, 2018 - 2030 (USD Million)
Table 6 Europe Equine Healthcare Market, Distribution Channel, 2018 - 2030 (USD Million)
Table 7 Europe Equine Healthcare Market, by Country, 2018 - 2030 (USD Million)
Table 8 Germany Equine Healthcare Market, Product Type, 2018 - 2030 (USD Million)
Table 9 Germany Equine Healthcare Market, Indication, 2018 - 2030 (USD Million)
Table 10 Germany Equine Healthcare Market, Activity Type, 2018 - 2030 (USD Million)
Table 11 Germany Equine Healthcare Market, Distribution Channel, 2018 - 2030 (USD Million)
Table 12 UK Equine Healthcare Market, Product Type, 2018 - 2030 (USD Million)
Table 13 UK Equine Healthcare Market, Indication, 2018 - 2030 (USD Million)
Table 14 UK Equine Healthcare Market, Activity Type, 2018 - 2030 (USD Million)
Table 15 UK Equine Healthcare Market, Distribution Channel, 2018 - 2030 (USD Million)
Table 16 France Equine Healthcare Market, Product Type, 2018 - 2030 (USD Million)
Table 17 France Equine Healthcare Market, Indication, 2018 - 2030 (USD Million)
Table 18 France Equine Healthcare Market, Activity Type, 2018 - 2030 (USD Million)
Table 19 France Equine Healthcare Market, Distribution Channel, 2018 - 2030 (USD Million)
Table 20 Italy Equine Healthcare Market, Product Type, 2018 - 2030 (USD Million)
Table 21 Italy Equine Healthcare Market, Indication, 2018 - 2030 (USD Million)
Table 22 Italy Equine Healthcare Market, Activity Type, 2018 - 2030 (USD Million)
Table 23 Italy Equine Healthcare Market, Distribution Channel, 2018 - 2030 (USD Million)
Table 24 Spain Equine Healthcare Market, Product Type, 2018 - 2030 (USD Million)
Table 25 Spain Equine Healthcare Market, Indication, 2018 - 2030 (USD Million)
Table 26 Spain Equine Healthcare Market, Activity Type, 2018 - 2030 (USD Million)
Table 27 Spain Equine Healthcare Market, Distribution Channel, 2018 - 2030 (USD Million)
Table 28 Sweden Equine Healthcare Market, Product Type, 2018 - 2030 (USD Million)
Table 29 Sweden Equine Healthcare Market, Indication, 2018 - 2030 (USD Million)
Table 30 Sweden Equine Healthcare Market, Activity Type, 2018 - 2030 (USD Million)
Table 31 Sweden Equine Healthcare Market, Distribution Channel, 2018 - 2030 (USD Million)
Table 32 Norway Equine Healthcare Market, Product Type, 2018 - 2030 (USD Million)
Table 33 Norway Equine Healthcare Market, Indication, 2018 - 2030 (USD Million)
Table 34 Norway Equine Healthcare Market, Activity Type, 2018 - 2030 (USD Million)
Table 35 Norway Equine Healthcare Market, Distribution Channel, 2018 - 2030 (USD Million)
Table 36 Denmark Equine Healthcare Market, Product Type, 2018 - 2030 (USD Million)
Table 37 Denmark Equine Healthcare Market, Indication, 2018 - 2030 (USD Million)
Table 38 Denmark Equine Healthcare Market, Activity Type, 2018 - 2030 (USD Million)
Table 39 Denmark Equine Healthcare Market, Distribution Channel, 2018 - 2030 (USD Million)
Table 40 Netherlands Equine Healthcare Market, Product Type, 2018 - 2030 (USD Million)
Table 41 Netherlands Equine Healthcare Market, Indication, 2018 - 2030 (USD Million)
Table 42 Netherlands Equine Healthcare Market, Activity Type, 2018 - 2030 (USD Million)
Table 43 Netherlands Equine Healthcare Market, Distribution Channel, 2018 - 2030 (USD Million)
Table 44 Russia Equine Healthcare Market, Product Type, 2018 - 2030 (USD Million)
Table 45 Russia Equine Healthcare Market, Indication, 2018 - 2030 (USD Million)
Table 46 Russia Equine Healthcare Market, Activity Type, 2018 - 2030 (USD Million)
Table 47 Russia Equine Healthcare Market, Distribution Channel, 2018 - 2030 (USD Million)
Table 48 Switzerland Equine Healthcare Market, Product Type, 2018 - 2030 (USD Million)
Table 49 Switzerland Equine Healthcare Market, Indication, 2018 - 2030 (USD Million)
Table 50 Switzerland Equine Healthcare Market, Activity Type, 2018 - 2030 (USD Million)
Table 51 Switzerland Equine Healthcare Market, Distribution Channel, 2018 - 2030 (USD Million)
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Europe Equine Healthcare Market, Product Type, 2018 - 2030 (USD Million)
Table 4 Europe Equine Healthcare Market, Indication, 2018 - 2030 (USD Million)
Table 5 Europe Equine Healthcare Market, Activity Type, 2018 - 2030 (USD Million)
Table 6 Europe Equine Healthcare Market, Distribution Channel, 2018 - 2030 (USD Million)
Table 7 Europe Equine Healthcare Market, by Country, 2018 - 2030 (USD Million)
Table 8 Germany Equine Healthcare Market, Product Type, 2018 - 2030 (USD Million)
Table 9 Germany Equine Healthcare Market, Indication, 2018 - 2030 (USD Million)
Table 10 Germany Equine Healthcare Market, Activity Type, 2018 - 2030 (USD Million)
Table 11 Germany Equine Healthcare Market, Distribution Channel, 2018 - 2030 (USD Million)
Table 12 UK Equine Healthcare Market, Product Type, 2018 - 2030 (USD Million)
Table 13 UK Equine Healthcare Market, Indication, 2018 - 2030 (USD Million)
Table 14 UK Equine Healthcare Market, Activity Type, 2018 - 2030 (USD Million)
Table 15 UK Equine Healthcare Market, Distribution Channel, 2018 - 2030 (USD Million)
Table 16 France Equine Healthcare Market, Product Type, 2018 - 2030 (USD Million)
Table 17 France Equine Healthcare Market, Indication, 2018 - 2030 (USD Million)
Table 18 France Equine Healthcare Market, Activity Type, 2018 - 2030 (USD Million)
Table 19 France Equine Healthcare Market, Distribution Channel, 2018 - 2030 (USD Million)
Table 20 Italy Equine Healthcare Market, Product Type, 2018 - 2030 (USD Million)
Table 21 Italy Equine Healthcare Market, Indication, 2018 - 2030 (USD Million)
Table 22 Italy Equine Healthcare Market, Activity Type, 2018 - 2030 (USD Million)
Table 23 Italy Equine Healthcare Market, Distribution Channel, 2018 - 2030 (USD Million)
Table 24 Spain Equine Healthcare Market, Product Type, 2018 - 2030 (USD Million)
Table 25 Spain Equine Healthcare Market, Indication, 2018 - 2030 (USD Million)
Table 26 Spain Equine Healthcare Market, Activity Type, 2018 - 2030 (USD Million)
Table 27 Spain Equine Healthcare Market, Distribution Channel, 2018 - 2030 (USD Million)
Table 28 Sweden Equine Healthcare Market, Product Type, 2018 - 2030 (USD Million)
Table 29 Sweden Equine Healthcare Market, Indication, 2018 - 2030 (USD Million)
Table 30 Sweden Equine Healthcare Market, Activity Type, 2018 - 2030 (USD Million)
Table 31 Sweden Equine Healthcare Market, Distribution Channel, 2018 - 2030 (USD Million)
Table 32 Norway Equine Healthcare Market, Product Type, 2018 - 2030 (USD Million)
Table 33 Norway Equine Healthcare Market, Indication, 2018 - 2030 (USD Million)
Table 34 Norway Equine Healthcare Market, Activity Type, 2018 - 2030 (USD Million)
Table 35 Norway Equine Healthcare Market, Distribution Channel, 2018 - 2030 (USD Million)
Table 36 Denmark Equine Healthcare Market, Product Type, 2018 - 2030 (USD Million)
Table 37 Denmark Equine Healthcare Market, Indication, 2018 - 2030 (USD Million)
Table 38 Denmark Equine Healthcare Market, Activity Type, 2018 - 2030 (USD Million)
Table 39 Denmark Equine Healthcare Market, Distribution Channel, 2018 - 2030 (USD Million)
Table 40 Netherlands Equine Healthcare Market, Product Type, 2018 - 2030 (USD Million)
Table 41 Netherlands Equine Healthcare Market, Indication, 2018 - 2030 (USD Million)
Table 42 Netherlands Equine Healthcare Market, Activity Type, 2018 - 2030 (USD Million)
Table 43 Netherlands Equine Healthcare Market, Distribution Channel, 2018 - 2030 (USD Million)
Table 44 Russia Equine Healthcare Market, Product Type, 2018 - 2030 (USD Million)
Table 45 Russia Equine Healthcare Market, Indication, 2018 - 2030 (USD Million)
Table 46 Russia Equine Healthcare Market, Activity Type, 2018 - 2030 (USD Million)
Table 47 Russia Equine Healthcare Market, Distribution Channel, 2018 - 2030 (USD Million)
Table 48 Switzerland Equine Healthcare Market, Product Type, 2018 - 2030 (USD Million)
Table 49 Switzerland Equine Healthcare Market, Indication, 2018 - 2030 (USD Million)
Table 50 Switzerland Equine Healthcare Market, Activity Type, 2018 - 2030 (USD Million)
Table 51 Switzerland Equine Healthcare Market, Distribution Channel, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Clinical Trials Market, Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 12 Porter’s Five Forces Analysis
Fig. 13 Regional Marketplace: Key Takeaways
Fig. 14 Europe Equine Healthcare Market, for Product Type, 2018 - 2030 (USD Million)
Fig. 15 Europe Equine Healthcare Market, for Pharmaceuticals, 2018 - 2030 (USD Million)
Fig. 16 Europe Equine Healthcare Market, for Parasiticides, 2018 - 2030 (USD Million)
Fig. 17 Europe Equine Healthcare Market, for Anti-infectives, 2018 - 2030 (USD Million)
Fig. 18 Europe Equine Healthcare Market, for Anti-inflammatory & Analgesics, 2018 - 2030 (USD Million)
Fig. 19 Europe Equine Healthcare Market, for Other Pharmaceuticals, 2018 - 2030 (USD Million)
Fig. 20 Europe Equine Healthcare Market, for Diagnostics, 2018 - 2030 (USD Million)
Fig. 21 Europe Equine Healthcare Market, for Diagnostic Test Kits, 2018 - 2030 (USD Million)
Fig. 22 Europe Equine Healthcare Market, for Diagnostic Equipment, 2018 - 2030 (USD Million)
Fig. 23 Europe Equine Healthcare Market, for Software, 2018 - 2030 (USD Million)
Fig. 24 Europe Equine Healthcare Market, for Practice Management Software, 2018 - 2030 (USD Million)
Fig. 25 Europe Equine Healthcare Market, for Imaging Software, 2018 - 2030 (USD Million)
Fig. 26 Europe Equine Healthcare Market, for Telehealth Software, 2018 - 2030 (USD Million)
Fig. 27 Europe Equine Healthcare Market, for Other Software, 2018 - 2030 (USD Million)
Fig. 28 Europe Equine Healthcare Market, for Indication, 2018 - 2030 (USD Million)
Fig. 29 Europe Equine Healthcare Market, for Musculoskeletal Disorders, 2018 - 2030 (USD Million)
Fig. 30 Europe Equine Healthcare Market, for Parasitic Infections, 2018 - 2030 (USD Million)
Fig. 31 Europe Equine Healthcare Market, for Equine Herpes Virus, 2018 - 2030 (USD Million)
Fig. 32 Europe Equine Healthcare Market, for Equine Viral Arteritis (EVA), 2018 - 2030 (USD Million)
Fig. 33 Europe Equine Healthcare Market, for Equine Influenza, 2018 - 2030 (USD Million)
Fig. 34 Europe Equine Healthcare Market, for West Nile Virus, 2018 - 2030 (USD Million)
Fig. 35 Europe Equine Healthcare Market, for Tetanus, 2018 - 2030 (USD Million)
Fig. 36 Europe Equine Healthcare Market, for Other Indications, 2018 - 2030 (USD Million)
Fig. 37 Europe Equine Healthcare Market, for Activity Type, 2018 - 2030 (USD Million)
Fig. 38 Europe Equine Healthcare Market, for Sports/Racing, 2018 - 2030 (USD Million)
Fig. 39 Europe Equine Healthcare Market, for Recreation, 2018 - 2030 (USD Million)
Fig. 40 Europe Equine Healthcare Market, for Other Activities, 2018 - 2030 (USD Million)
Fig. 41 Europe Equine Healthcare Market, for Distribution Channel, 2018 - 2030 (USD Million)
Fig. 42 Europe Equine Healthcare Market, for Veterinary Hospitals & Clinics, 2018 - 2030 (USD Million)
Fig. 43 Europe Equine Healthcare Market, for E-commerce, 2018 - 2030 (USD Million)
Fig. 44 Europe Equine Healthcare Market, for Equestrian Facilities, 2018 - 2030 (USD Million)
Fig. 45 Europe Equine Healthcare Market, for Other Channels, 2018 - 2030 (USD Million)
Fig. 46 Country Outlook, 2023 & 2030
Fig. 47 Germany Equine Healthcare Market, 2018 - 2030 (USD Million)
Fig. 48 UK Equine Healthcare Market, 2018 - 2030 (USD Million)
Fig. 49 France Equine Healthcare Market, 2018 - 2030 (USD Million)
Fig. 50 Italy Equine Healthcare Market, 2018 - 2030 (USD Million)
Fig. 51 Spain Equine Healthcare Market, 2018 - 2030 (USD Million)
Fig. 52 Sweden Equine Healthcare Market, 2018 - 2030 (USD Million)
Fig. 53 Norway Equine Healthcare Market, 2018 - 2030 (USD Million)
Fig. 54 Denmark Equine Healthcare Market, 2018 - 2030 (USD Million)
Fig. 55 Netherlands Equine Healthcare Market, 2018 - 2030 (USD Million)
Fig. 56 Russia Equine Healthcare Market, 2018 - 2030 (USD Million)
Fig. 57 Switzerland Equine Healthcare Market, 2018 - 2030 (USD Million)
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Clinical Trials Market, Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 12 Porter’s Five Forces Analysis
Fig. 13 Regional Marketplace: Key Takeaways
Fig. 14 Europe Equine Healthcare Market, for Product Type, 2018 - 2030 (USD Million)
Fig. 15 Europe Equine Healthcare Market, for Pharmaceuticals, 2018 - 2030 (USD Million)
Fig. 16 Europe Equine Healthcare Market, for Parasiticides, 2018 - 2030 (USD Million)
Fig. 17 Europe Equine Healthcare Market, for Anti-infectives, 2018 - 2030 (USD Million)
Fig. 18 Europe Equine Healthcare Market, for Anti-inflammatory & Analgesics, 2018 - 2030 (USD Million)
Fig. 19 Europe Equine Healthcare Market, for Other Pharmaceuticals, 2018 - 2030 (USD Million)
Fig. 20 Europe Equine Healthcare Market, for Diagnostics, 2018 - 2030 (USD Million)
Fig. 21 Europe Equine Healthcare Market, for Diagnostic Test Kits, 2018 - 2030 (USD Million)
Fig. 22 Europe Equine Healthcare Market, for Diagnostic Equipment, 2018 - 2030 (USD Million)
Fig. 23 Europe Equine Healthcare Market, for Software, 2018 - 2030 (USD Million)
Fig. 24 Europe Equine Healthcare Market, for Practice Management Software, 2018 - 2030 (USD Million)
Fig. 25 Europe Equine Healthcare Market, for Imaging Software, 2018 - 2030 (USD Million)
Fig. 26 Europe Equine Healthcare Market, for Telehealth Software, 2018 - 2030 (USD Million)
Fig. 27 Europe Equine Healthcare Market, for Other Software, 2018 - 2030 (USD Million)
Fig. 28 Europe Equine Healthcare Market, for Indication, 2018 - 2030 (USD Million)
Fig. 29 Europe Equine Healthcare Market, for Musculoskeletal Disorders, 2018 - 2030 (USD Million)
Fig. 30 Europe Equine Healthcare Market, for Parasitic Infections, 2018 - 2030 (USD Million)
Fig. 31 Europe Equine Healthcare Market, for Equine Herpes Virus, 2018 - 2030 (USD Million)
Fig. 32 Europe Equine Healthcare Market, for Equine Viral Arteritis (EVA), 2018 - 2030 (USD Million)
Fig. 33 Europe Equine Healthcare Market, for Equine Influenza, 2018 - 2030 (USD Million)
Fig. 34 Europe Equine Healthcare Market, for West Nile Virus, 2018 - 2030 (USD Million)
Fig. 35 Europe Equine Healthcare Market, for Tetanus, 2018 - 2030 (USD Million)
Fig. 36 Europe Equine Healthcare Market, for Other Indications, 2018 - 2030 (USD Million)
Fig. 37 Europe Equine Healthcare Market, for Activity Type, 2018 - 2030 (USD Million)
Fig. 38 Europe Equine Healthcare Market, for Sports/Racing, 2018 - 2030 (USD Million)
Fig. 39 Europe Equine Healthcare Market, for Recreation, 2018 - 2030 (USD Million)
Fig. 40 Europe Equine Healthcare Market, for Other Activities, 2018 - 2030 (USD Million)
Fig. 41 Europe Equine Healthcare Market, for Distribution Channel, 2018 - 2030 (USD Million)
Fig. 42 Europe Equine Healthcare Market, for Veterinary Hospitals & Clinics, 2018 - 2030 (USD Million)
Fig. 43 Europe Equine Healthcare Market, for E-commerce, 2018 - 2030 (USD Million)
Fig. 44 Europe Equine Healthcare Market, for Equestrian Facilities, 2018 - 2030 (USD Million)
Fig. 45 Europe Equine Healthcare Market, for Other Channels, 2018 - 2030 (USD Million)
Fig. 46 Country Outlook, 2023 & 2030
Fig. 47 Germany Equine Healthcare Market, 2018 - 2030 (USD Million)
Fig. 48 UK Equine Healthcare Market, 2018 - 2030 (USD Million)
Fig. 49 France Equine Healthcare Market, 2018 - 2030 (USD Million)
Fig. 50 Italy Equine Healthcare Market, 2018 - 2030 (USD Million)
Fig. 51 Spain Equine Healthcare Market, 2018 - 2030 (USD Million)
Fig. 52 Sweden Equine Healthcare Market, 2018 - 2030 (USD Million)
Fig. 53 Norway Equine Healthcare Market, 2018 - 2030 (USD Million)
Fig. 54 Denmark Equine Healthcare Market, 2018 - 2030 (USD Million)
Fig. 55 Netherlands Equine Healthcare Market, 2018 - 2030 (USD Million)
Fig. 56 Russia Equine Healthcare Market, 2018 - 2030 (USD Million)
Fig. 57 Switzerland Equine Healthcare Market, 2018 - 2030 (USD Million)
